← SynDRA
EPROBEMIDE
SynDRA canonical compound SYN0030408 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | MAOA |
|---|
| Mechanism of action | Monoamine oxidase inhibitor |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Monoamine oxidase inhibitor
Cross-references
Synonyms
- Eprobemida
- 4-chloro-N-[3-(morpholin-4-yl)propyl]benzamide
- Eprobemide [INN]
- LIS 630
- 4-chloro-N-(3-morpholin-4-ylpropyl)benzamide
- URX5F7RDER
- NCGC00164516-01
- NCGC00164516-02
- p-Chloro-N-(3-morpholinopropyl)benzamide
- 4-Chloro-N-[3-(4-morpholinyl)propyl]benzamide
- Eprobemidum
- CAS-87940-60-1
- UNII-URX5F7RDER
- Eprobemidum [INN-Latin]
- Eprobemida [INN-Spanish]
- befole
- CBMicro_028607
- Eprobemide (LIS 630)
- SCHEMBL570896
- CHEMBL2104298
- DTXSID3046409
- BCP30208
- HY-B1413
- Tox21 112151
- Tox21_112151
- BDBM50276876
- s2419
- STK415747
- ZINC19593518
- AKOS002663030
- Tox21_112151_1
- CCG-213898
- LIS 630;LIS630;LIS-630
- 4-Chloro-N-(3-morpholinopropyl)benzamide
- BS-17747
- BIM-0028524.P001
- CS-0013131
- D81891
Look up EPROBEMIDE in the interactive SynDRA portal →